- Exchange: AktieTorget
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for WntResearch AB (WNT)
| Open: | 15.2000 | Day's Range: | 13.7000 - 15.6000 | Volume: | 305,207 |
|---|---|---|---|---|---|
| Previous Close: | 15.2000 | 52wk Range: | 2.7200 - 15.7000 | 1-Yr Rtn: | +189.93% |
Key Statistics for WNT
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. OMX | - |
| Earnings Per Share (ttm) | -0.7237 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M SEK) | 140.17 |
| Shares Outstanding (M) | 10.05 |
| 30 Day Average Volume | 118,538 |
| Price/Book (mrq) | 14.3159 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for WNT
No data available
Company Profile & Key Executives for WNT
WntResearch AB is a cancer research company. The Company develops anti-metastatic therapies based on an understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process.
| Peter Buhl JensenChairman | Tommy AnderssonChief Scientific Officer |
| Nils BrunnerScientific Advisor | Ulla Hald BuhlScientific Adviser |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
WNT News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page